|会社名||Cronos Group Inc （クロノス・グル―プ）|
|分野（sector）||Consumer Durables 耐久消費財|
|業種||― 医療関連（Health Care）|
|概要||事業概要 -- クロノス・グル―プはカナダの医療用大麻事業会社。医療目的大麻規制(MMPR)に基づき、カナダ保健省が発行した医療用大麻生産ライセンスを所有または申請する企業への投資を中心に事業を行う。また、子会社を通じ、大麻油の栽培や医療用大麻の生産および販売にも従事する。本社所在地はトロント。 Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group's portfolio includes PEACE NATURALS™, a global wellness platform, two adult-use brands, COVE™ and Spinach™, and three hemp-derived CBD brands, Lord Jones™, Happy Dance™ and PEACE+™.|
|本社所在地||720 King Street West Suite 320 Toronto Ontario M5V 2T3 CAN|
|市場名||NASDAQ National Market System|
Extreme fear keeps Cronos consolidated even as Crypto.com DeFi wallet integrates with OpenSea 2022/10/03 21:38:22 FXStreet
Read more on https://www.fxstreet.com
Chainlink (LINK) And Cronos (CRO) Post Positive Moves Amidst Market Uncertainty | Crypto Breaking News 2022/09/30 01:45:50 Crypto Breaking News
Chainlink (LINK) and Cronos (CRO) have recently enjoyed positive price movements, despite the market’s uncertainty over cryptocurrencies. Both tokens
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market 2022/09/27 11:15:11 InvestorPlace
These are seven of the best stocks to buy that can see substantial returns in the months ahead. Despite the ongoing worries on Wall Street, seasoned investors realize that there may be a bull market in some segments of the market even during these gloomy weeks. Fears of sticky inflation and recession led to many investors reevaluating their investments or pulling their money out of the stock markets altogether. As a result, the S&P 500 index has dropped 23% year to date, while the tech-heavy NASDAQ 100 has lost close to a third of its value. However, for investors who research further, there is always a chance to find the best stocks to buy in a hidden bull market. Including several of those shares could help boost the performance of investment portfolios despite the overall market chaos. Even in 2022, with interest rates hitting a 14-year high in the U.S. and stocks getting hammered, we are experiencing localized bull markets in the energy and utility sectors. For instance, the energy sector, overall, has returned around 18% since January.
4 Deeply Undervalued Dividend Stocks With Yields Over 5% 2022/09/26 18:33:06 InvestorPlace
The year 2022 has been challenging for many investors. Making money seems complicated when inflation is high, and returns in several asset classes remain negative. However, investing in undervalued dividend stocks with high yields is an effective way to combat the current bear market. As a result, many investors have shifted their focus towards blue-chip stocks. For now, the healthy dividend yield in these stocks ensure regular cash flow for investors. With a strong balance sheet and healthy operating cash flows, dividends are sustainable even if the industry faces near-term headwinds. Furthermore, as overall market conditions improve, these undervalued dividend stocks are poised for a meaningful rally. Investors are therefore positioned to benefit from dividend and capital gains in these fundamentally strong stocks. While it’s an excellent time to accumulate undervalued growth stocks, I would remain overweight on blue-chip dividend stocks. It’s a bonus if these stocks are available at a valuation gap.
4 No-Brainer Penny Stocks to Buy if You Have Money to Invest 2022/09/26 13:45:43 InvestorPlace
Penny stocks have always fascinated investors. That’s because higher-risk, lower-priced penny stocks to buy can be portfolio game-changers. While it’s never a good idea to go overweight on penny stocks, investors can always safely allocate 10% to 20% to these stocks. We should also note that penny stocks are not purely speculative. In fact, there are emerging businesses that can make it big in the long-term. Oftentimes, exposure to these penny stocks can be rewarding over a period of three to five years. Granted, current markets find themselves in uncertain times. All thanks to inflation, interest rate hikes and GDP growth. Still, it’s not difficult to spot deeply undervalued penny stocks to buy. Some allocation to these stocks is helpful in creating a diversified portfolio. Let’s take a deeper look into four penny stocks to buy. HRTX Heron Therapeutics $3.98 MNSO MINISO Group $4.60 BITF Bitfarms $1.04 CRON Cronos Group $2.83 Heron Therapeutics (HRTX) Source: ra2 studio/Shutterstock Heron Therapeutics is one of the top penny stocks to buy.
Volatility Of Cannabis Stocks: Schumer''s Bill Was A ''Hail Mary'', But Industry Has Other Catalysts – Experts Explain 2022/08/01 16:03:49 Benzinga
This was a very challenging year for pot stocks . Year-to-date, AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) dropped 54.01%, AdvisorShares Pure Cannabis ETF (ARCA:YOLO) declined 57.46%, compared to SPDR S&P 500 (ARCA:SPY) which lost 13.61%. Looking into some of the biggest cannabis players out there, the situation is pretty much the same. Since the beginning of the year Aurora Cannabis (NASDAQ: ACB ) fell 75.57%, Tilray (NASDAQ: TLRY ) plummeted 51.96%, Canopy Growth (NASDAQ: CGC ) lost 70.29%, Cronos Group (NASDAQ: CRON ) declined 24.17%. Despite the harsh market conditions, reports that long-awaited legislation was finally introduced sent cannabis stocks soaring . The bill from Senate Majority Leader Chuck Schumer , Senators Ron Wyden and Cory Booker - the Cannabis Administration And Opportunity Act (CAOA) - was presented on July 21st. There’s no doubt that the passage of any of a number of cannabis-related reforms would have a similar effect on pot stocks. The question is – how long will the rally last?
Cronos Stock: Too Much Cash, Too Soon - Making The Bear Case (NASDAQ:CRON) 2022/08/01 13:12:41 Seeking Alpha
I can see Cronos'' market cap valuation shrinking at the same pace as its funds. Read more to see why I believe CRON is not a viable investment opportunity now.
Cronos upgraded to buy at Canaccord Genuity on cash reserves, expected sales increase 2022/07/28 15:19:23 Seeking Alpha
Ahead of its fiscal 2023 Q1 earnings on Aug. 9, Canaccord Genuity has upgraded Canadian cannabis company Cronos Group (CRON) to buy from hold citing favorable cash reserves and sales boost.
5 Medical Marijuana Stocks to Buy Now 2022/07/28 13:13:38 Insider Monkey
In this article, we discuss 5 medical marijuana stocks to invest in. If you want to read our comprehensive analysis of these stocks and the current market situation, go directly to 10 Medical Marijuana Stocks to Buy Now. 5. Cronos Group Inc. (NASDAQ:CRON) Number Of Hedge Fund Holders: 9 Cronos Group, Inc. (NASDAQ:CRON) is a […]
Canaccord Genuity Upgrades Cronos Group to Buy 2022/07/28 11:52:05 Investing.com
7 Large Cap Stocks to Buy for Long-Term Stability 2022/06/10 11:20:22 InvestorPlace
Large-cap stocks are dividend aristocrats with steady returns and low beta. Growth stocks are the portfolio upside catalysts and can deliver multi-fold returns. It, therefore, makes sense to have a portfolio that’s a blend of growth and large-cap stocks. In the last 10-years, the Vanguard Large Cap ETF (NYSERCA: VV ) has delivered annualized returns of 14.22% . During the same period, the Vanguard Growth ETF (NYSEARCA: VUG ) has given annualized returns of 15.23% . 7 of the Hottest ETFs to Buy Right Now Besides providing stability to the portfolio, large-cap stocks have also matched returns of growth stocks in this period. Even if the same is not replicated in the next 10-years, it still makes sense to hold quality large cap stocks. In the recent market correction, dozens of high-flying growth stocks have plunged by more than 50%. This underscores the importance of having a balanced portfolio. PFE Pfizer $51.78 LMT Lockheed Martin $432.72 WMT Walmart $121.02 CVX Chevron $177.52 MO Altria $48.66 AAPL Apple $142.64 AMZN Amazon $116.15 Pfizer (PFE) Source: photobyphm / Shutterstock.com With the stock trading at a forward price-to-earnings-ratio of 7.8 and offering a dividend yield of 3.0% Pfizer (NYSE: PFE ) is among my favorite large-cap stocks.
Marijuana Stock Movers For June 7, 2022 2022/06/07 20:57:21 Benzinga
GAINERS: Charlottes Web Holdings (OTC: CWBHF ) shares closed up 15.94% at $0.53 Nine Energy Service (NYSE: NINE ) shares closed up 13.18% at $3.95 Mexco Energy (AMEX: MXC ) shares closed up 11.41% at $22.21 MGC Pharmaceuticals (OTC: MGCLF ) shares closed up 9.49% at $0.01 HEXO (NASDAQ: HEXO ) shares closed up 6.73% at $0.27 Cronos Group (NASDAQ: CRON ) shares closed up 5.57% at $3.03 OrganiGram Holdings (NASDAQ: OGI ) shares closed up 5.56% at $1.14 Cara Therapeutics (NASDAQ: CARA ) shares closed up 5.46% at $8.88 Aurora Cannabis (NASDAQ: Full story available on Benzinga.com
TSX Slightly in Green 2022/06/07 16:17:00 Baystreet Canada
Equities in Canada’s largest centre regained lost ground midday and exhibited slight gains on Tuesday, as investors awaited U.S. inflation data and the European Central Bank meeting to gauge the path of monetary policy. The S&P/TSX recovered 18.45 points to pause for lunch Tuesday at 20,837.54 The Canadian dollar added 0.19 cents to 79.67cents U.S. The largest percentage gainers on the TSX were Cronos Group, which jumped 12 cents, or 3.3%, to $3.71, and Arc Resources, which rose 75 cents, or 3.6%, to $21.54. Aritzia fell $1.15, or 3%, the most on the TSX, to $37.46, and the second-biggest decliner was NFI Group, down 44 cents, or 3.2%, to $13.35. On the economic slate, Statistics Canada says growth in Canadian merchandise imports and exports slowed in April, with imports rising 1.9% and exports increasing 0.6%. As a result, the agency concludes, Canada''s merchandise trade surplus with the world narrowed from $2.3 billion in March to $1.5 billion in April. The IVEY PMI for May ballooned to 72 in May, from 66.3 in April and showed a vast improvement over the 64.7 figure for May 2021.
Cannabis Stocks ACB, CGC, TLRY Fall as Earnings Disappoint 2022/05/27 14:17:44 InvestorPlace
Source: Jetacom Autofocus / Shutterstock.com Many cannabis stocks are declining today after one of the largest companies in the sector, Canopy Growth (NASDAQ: CGC ), reported fiscal fourth-quarter results that were significantly below analysts’ average estimates. CGC stock is tumbling 15% in early trading. Meanwhile, another cannabis company, Aurora (NASDAQ: ACB ), announced that it would raise $150 million by selling stock and warrants. That news also seems to be putting downward pressure on cannabis stocks. Canopy’s Q4 Results The company’s Q4 revenue dropped 25% to 111.8 million CAD, well below analysts’ average estimate of 130.5 million CAD. The cannabis maker reported a per share loss of 1.46 Canadian dollars. That is also much wider than estimates for a loss of 21 cents CAD. Canopy CFO Judy Hong said: “Achieving profitability is critical and we have undertaken additional initiatives to streamline and drive efficiencies for our global cannabis business. … [W]e are focused on executing our path to profitability in Canada, while we continue to invest in high potential opportunities.” The company added that it would seek to grow its business in the U.S.
Legal Cannabis Market size to increase by USD 34.91 Tn | 19.40% YOY growth observed in 2021 | Technavio 2022/05/27 03:00:00 Benzinga
NEW YORK , May 26, 2022 /PRNewswire/ -- The " Legal Cannabis Market by Product and Geography - Forecast and Analysis 2021-2025 " report has been added to Technavio''s offering. According to the report, the market will observe an incremental growth of USD 34.91 trillion between 2020 and 2025. The market witnessed a YOY growth of 19.40% in 2021 and the growth momentum is expected to accelerate at a CAGR of 21.39% during the forecast period. Download the Report Sample for more highlights on the market size, YOY growth rates, growth momentum, and other important statistics. The global legal cannabis market is fragmented due to the presence of several regional and global vendors. Intense competition, coupled with various stringent regulations, constitute significant risk factors to the operation of vendors. Hence, to survive and succeed in the competitive environment, it is imperative for manufacturers in the market to distinguish their product and service offerings through a clear and unique value proposition.
関連キーワード （― 米国株 クロノス・グル―プ CRON Cronos Group Inc.）